KR

Pipeline

Business Model

Pipeline

  • Drug Code
  • OC-101
  • OC-101 + OC-111
  • OC-201, 202
  • OC-501, 504
  • OC-501, 504
  • J pharma-001
  • J pharma-002
  • KRICT-001~005
  • BI-001~005
  • Indication
  • Liver cirrhosis
  • Fatty Liver
  • Anti-Metastasis
  • Sarcopenia
  • ALS
  • NASH
  • Appropriate cancer
  • Various diseases
  • Various diseases
  • Drug
    Discovery
  • In vitro
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III

Patent

Application Registration
Korea patent 9 3
PCT 4
Individual country
- Liver cirrhosis 18 1 (Australia)
- Anti metastasis 6 0
- sarcopenia 3 0